| PERIOD ENDING | 31-Mar-03 | | Total Revenue | 1,273,000 | | Cost of Revenue | 409,000 | | | Gross Profit | 864,000 | | | Operating Expenses | | Research Development | 17,000 | | Selling General and Administrative | 168,000 | | Non Recurring |
-
| | Others | 303,000 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 376,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16,000 | | Earnings Before Interest And Taxes | 389,000 | | Interest Expense |
-
| | Income Before Tax | 389,000 | | Income Tax Expense | 82,000 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 307,000 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 307,000 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $307,000 |
|
0.09% Nasdaq 
0.32%
Income Statement
